News & Breakthroughs at Siteman

Stay informed with the latest cancer news and breakthroughs from Siteman Cancer Center. Our news feed provides timely updates on research breakthroughs, clinical trials, and community events.

In the Media News & Stories

A new NIH grant to WashU Medicine supports research into myeloproliferative neoplasms (MPNs), a group of blood cancers. In an MPN called myelofibrosis, reticulin fibers (in cyan) infiltrate the bone marrow.

Funding Opportunities, In the Media, Research

$11.7 Million From NIH Supports Research on Inflammation in Blood Cancers

September 29, 2026

Grant will fund four major projects, three core resources to study myeloproliferative neoplasms Researchers at WashU Medicine have received an $11.7 million grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) to study the role of inflammation in myeloproliferative neoplasms (MPNs), a group of blood cancers characterized by […]

Timothy J. Eberlein, MD, FACS, at his Sept. 26, 2026, American College of Surgeons presidential installation ceremony

In the Media, Staff/Faculty Update

Timothy J. Eberlein, MD, FACS, Installed as President of the American College of Surgeons

September 29, 2026

The founding director of Siteman Cancer Center, he was installed as the 107th president of the world’s largest surgeons’ organization Sept. 26 in Washington, D.C. Timothy J. Eberlein, MD, FACS, founding director of Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, has been installed as the 107th president of the American College of Surgeons (ACS), the world’s largest organization […]

Julie Schwarz, MD, PhD, and Clifford Robinson, MD

In the Media, Research, Scientific Seminars & Meetings

WashU Medicine Radiation Oncologists at Siteman Cancer Center to Showcase Findings at ASTRO 2026

September 24, 2026

From Phase III prostate cancer trials to first-in-human adaptive radiotherapy, WashU Medicine teams will highlight major advances at the 68th ASTRO Annual Meeting WashU Medicine physician-scientists and researchers affiliated with Siteman Cancer Center will present groundbreaking scientific and clinical advances at the 68th American Society for Radiation Oncology (ASTRO) Annual Meeting, Sept. 26-30 at the […]

Community members and faculty members and staff attend an unveiling ceremony for the new Siteman Lung Screening Van.

Community Screenings & Events, In the Media, Prevention

Siteman Cancer Center Mobilizes Lung Screening

September 19, 2026

A new mobile unit is hitting the road to deliver lifesaving cancer screening across the region. Committed to delivering more cancer screenings to more people, Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, is launching a new mobile resource to improve the health of individuals, families and communities — the only one of its kind for […]

A person with curly hair sits in an ornate chair, gazing thoughtfully to the side in a warmly lit room with a large plant and a bulletin board in the background.

Clinical, In the Media, Patient & Donor Stories

Liver Transplants Offer New Hope for Late-stage Colorectal Cancer

September 15, 2026

When Meghan and Mark Moore got married in 2021 at their home in suburban St. Louis, the group of close friends in attendance knew Meghan had been diagnosed with colon cancer just days earlier. Already, the tumor had spread to her liver, making her cancer stage 4 — an advanced diagnosis with limited treatment options. […]

Researcher and Oncologist Francesca Ferraro, MD, PhD

Clinical, In the Media, Research

Rising WashU Medicine Physician-Scientist Researches Ways to Prevent Recurrence in AML

September 11, 2026

Francesca Ferraro receives Damon Runyon Clinical Investigator Award for her acute myeloid leukemia work Francesca Ferraro, MD, PhD, a WashU Medicine researcher and medical oncologist at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine, has been named a 2026 Damon Runyon Clinical Investigator Award. The grant, given by the Damon Runyon Cancer Research Foundation, supports early-career […]

Assistant Professors Francesca Ferraro, MD, PhD, and Jaebok Choi, PhD

Clinical, In the Media, Research

WashU Medicine Researchers at Siteman Earn National Recognition for Leukemia Research

September 11, 2026

American Society of Hematology awards grants to Francesca Ferraro, Jaebok Choi Two WashU Medicine investigators at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, have been awarded prestigious grants from the American Society of Hematology (ASH), the world’s largest professional society serving clinicians and scientists working to conquer blood diseases. Francesca Ferraro, MD, […]

Photo of researcher Jessica Silva-Fisher

Clinical, In the Media, Research

Jessica Silva-Fisher Receives American Cancer Society Grant

September 2, 2026

WashU Medicine investigator at Siteman Cancer Center aims to study how chemical modifications to RNA contribute to the progression of multiple myeloma Jessica Silva-Fisher, PhD, a WashU Medicine scientist at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine, has received a Research Scholar Grant from the American Cancer Society (ACS) — one of only […]

Pickleball players taking a selfie

Health & Wellness, In the Media, Patient Education Resource, Prevention

For Your Health — What to Know About Dementia — and Ways to Prevent It

August 31, 2026

Dementia touches many lives — in many different ways. And most of us likely have some firsthand experience with it, whether it’s with an aging family member or friend or neighbor. Over 6 million people in the U.S. have some type of dementia, and these numbers are expected to accelerate in the coming years as […]

Illustration of the pancreas in the human body

Clinical, In the Media, Research

Newly Approved Pancreatic Cancer Treatment Has Been Shown To Prolong Life — And Highlights Siteman’s Role in Bringing Innovation to Patients

August 26, 2026

FDA approves first-in-class drug trialed at WashU Medicine and Siteman Cancer Center — a new option for patients with metastatic disease Daraxonrasib is a drug that targets RAS proteins, which are mutated in more than 90% of pancreatic cancers. As a clinical trial site, Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine evaluated the […]

Page 1 of 16